Global mRNA Vaccine And Therapeutics Market
94 Pages | Healthcare

Global mRNA Vaccine And Therapeutics Market Size, Status and Forecast 2021-2027

  • Published Date : 01-06-2021
  • Pages : 94
  • Report Id : 30443
  • Categories : Healthcare

mRNA vaccine is the drugs prepared using advanced technologies using mRNA as the genetic material. mRNA vaccines are a more efficient alternative owing to their enhanced immunogenicity, higher potency, rapid development, relatively cheaper and safer over conventional vaccines.
In 2020, the global mRNA Vaccine And Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

This report focuses on the global mRNA Vaccine And Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the mRNA Vaccine And Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Argos Therapeutics
BioNTech
CureVac
eTheRNA
Ethris
In-Cell-Art
Moderna Therapeutics
Sangamo Therapeutics
Tiba Biotechnology
Translate Bio

Market segment by Type, the product can be split into
Infectious Disease
Cancer
Others

Market segment by Application, split into
Hospital
Research Institual

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global mRNA Vaccine And Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the mRNA Vaccine And Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of mRNA Vaccine And Therapeutics are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type ( 2016-2027)
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Others
1.5 Market by Application
1.5.1 Global mRNA Vaccine And Therapeutics Market Share by Application ( 2021-2027)
1.5.2 Hospital
1.5.3 Research Institual
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 mRNA Vaccine And Therapeutics Market Size
2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions
2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions ( 2021-2027)
2.2.2 mRNA Vaccine And Therapeutics Market Share by Regions ( 2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter�s Five Forces Analysis

3 Market Share by Key Players
3.1 mRNA Vaccine And Therapeutics Market Size by by Players
3.1.1 Global mRNA Vaccine And Therapeutics Revenue by by Players ( 2016-2021)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by by Players ( 2016-2021)
3.1.3 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
3.3 Key Players mRNA Vaccine And Therapeutics Product/Solution/Service
3.4 Date of Enter into mRNA Vaccine And Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global mRNA Vaccine And Therapeutics Market Size by Type ( 2016-2021)
4.2 Global mRNA Vaccine And Therapeutics Market Size by Application ( 2016-2021)

5 North America
5.1 North America mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
5.2 mRNA Vaccine And Therapeutics Key Players in North America
5.3 North America mRNA Vaccine And Therapeutics Market Size by Type
5.4 North America mRNA Vaccine And Therapeutics Market Size by Application

6 Europe
6.1 Europe mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
6.2 mRNA Vaccine And Therapeutics Key Players in Europe
6.3 Europe mRNA Vaccine And Therapeutics Market Size by Type
6.4 Europe mRNA Vaccine And Therapeutics Market Size by Application

7 China
7.1 China mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
7.2 mRNA Vaccine And Therapeutics Key Players in China
7.3 China mRNA Vaccine And Therapeutics Market Size by Type
7.4 China mRNA Vaccine And Therapeutics Market Size by Application

8 Japan
8.1 Japan mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
8.2 mRNA Vaccine And Therapeutics Key Players in Japan
8.3 Japan mRNA Vaccine And Therapeutics Market Size by Type
8.4 Japan mRNA Vaccine And Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
9.2 mRNA Vaccine And Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type
9.4 Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application

10 India
10.1 India mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
10.2 mRNA Vaccine And Therapeutics Key Players in India
10.3 India mRNA Vaccine And Therapeutics Market Size by Type
10.4 India mRNA Vaccine And Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America mRNA Vaccine And Therapeutics Market Size ( 2016-2021)
11.2 mRNA Vaccine And Therapeutics Key Players in Central & South America
11.3 Central & South America mRNA Vaccine And Therapeutics Market Size by Type
11.4 Central & South America mRNA Vaccine And Therapeutics Market Size by Application

12 International Players Profiles
12.1 Argos Therapeutics
12.1.1 Argos Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 mRNA Vaccine And Therapeutics Introduction
12.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021))
12.1.5 Argos Therapeutics Recent Development
12.2 BioNTech
12.2.1 BioNTech Company Details
12.2.2 Company Description and Business Overview
12.2.3 mRNA Vaccine And Therapeutics Introduction
12.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.2.5 BioNTech Recent Development
12.3 CureVac
12.3.1 CureVac Company Details
12.3.2 Company Description and Business Overview
12.3.3 mRNA Vaccine And Therapeutics Introduction
12.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.3.5 CureVac Recent Development
12.4 eTheRNA
12.4.1 eTheRNA Company Details
12.4.2 Company Description and Business Overview
12.4.3 mRNA Vaccine And Therapeutics Introduction
12.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.4.5 eTheRNA Recent Development
12.5 Ethris
12.5.1 Ethris Company Details
12.5.2 Company Description and Business Overview
12.5.3 mRNA Vaccine And Therapeutics Introduction
12.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.5.5 Ethris Recent Development
12.6 In-Cell-Art
12.6.1 In-Cell-Art Company Details
12.6.2 Company Description and Business Overview
12.6.3 mRNA Vaccine And Therapeutics Introduction
12.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.6.5 In-Cell-Art Recent Development
12.7 Moderna Therapeutics
12.7.1 Moderna Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 mRNA Vaccine And Therapeutics Introduction
12.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.7.5 Moderna Therapeutics Recent Development
12.8 Sangamo Therapeutics
12.8.1 Sangamo Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 mRNA Vaccine And Therapeutics Introduction
12.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.8.5 Sangamo Therapeutics Recent Development
12.9 Tiba Biotechnology
12.9.1 Tiba Biotechnology Company Details
12.9.2 Company Description and Business Overview
12.9.3 mRNA Vaccine And Therapeutics Introduction
12.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.9.5 Tiba Biotechnology Recent Development
12.10 Translate Bio
12.10.1 Translate Bio Company Details
12.10.2 Company Description and Business Overview
12.10.3 mRNA Vaccine And Therapeutics Introduction
12.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business ( 2016-2021)
12.10.5 Translate Bio Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Product ( 2021-2027)
13.2 Market Size Forecast by Application ( 2021-2027)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table mRNA Vaccine And Therapeutics Key Market Segments
Table Key Players mRNA Vaccine And Therapeutics Covered
Table Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type 2020-2027 (Million US$)
Figuer Infectious Disease Figures
Table Key Players of Infectious Disease
Figuer Cancer Figures
Table Key Players of Cancer
Figuer Others Figures
Table Key Players of Others
Table Global mRNA Vaccine And Therapeutics Market Size Growth by Application 2021-2027 (Million US$)
Figure Global mRNA Vaccine And Therapeutics Market Share by Application in 2020 & 2027
Figure Hospital Case Studies
Figure Research Institual Case Studies
Figure mRNA Vaccine And Therapeutics Report Years Considered
Figure Global mRNA Vaccine And Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Size by Regions 2021-2027 (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Size by Regions 2021-2027 (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Share by Regions 2016-2021
Figure Global mRNA Vaccine And Therapeutics Market Share by Regions 2016-2021
Figure Global mRNA Vaccine And Therapeutics Market Share by Regions in 2020
Table Market Top Trends
Table Key Drivers: Impact Analysis ( 2021-2027)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global mRNA Vaccine And Therapeutics Revenue by by Players ( 2016-2021) (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Share by by Players ( 2016-2021)
Figure Global mRNA Vaccine And Therapeutics Market Share by by Players in 2020
Table Global mRNA Vaccine And Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players mRNA Vaccine And Therapeutics Product/Solution/Service
Table Date of Enter into mRNA Vaccine And Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global mRNA Vaccine And Therapeutics Market Size by Type ( 2016-2021) (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Size Share by Type ( 2016-2021)
Figure Global mRNA Vaccine And Therapeutics Market Size Market Share by Type ( 2016-2021)
Table Global mRNA Vaccine And Therapeutics Market Size by Application ( 2016-2021) (Million US$)
Table Global mRNA Vaccine And Therapeutics Market Size Share by Application ( 2016-2021)
Figure Global mRNA Vaccine And Therapeutics Market Size Market Share by Application ( 2016-2021)
Figure Global mRNA Vaccine And Therapeutics Revenue Market Share by Application in 2020
Figure North America mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table North America Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table North America Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table North America mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table North America mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table North America mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table North America mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure Europe mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table Europe Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table Europe Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table Europe mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Europe mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table Europe mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Europe mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure China mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table China Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table China Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table China mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table China mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table China mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table China mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure Japan mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table Japan Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table Japan Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table Japan mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Japan mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table Japan mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Japan mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure Southeast Asia mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table Southeast Asia Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table Southeast Asia mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Southeast Asia mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table Southeast Asia mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Southeast Asia mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure India mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table India Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table India Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table India mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table India mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table India mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table India mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Figure Central & South America mRNA Vaccine And Therapeutics Market Size 2016-2021 (Million US$)
Table Central & South America Key Players mRNA Vaccine And Therapeutics Revenue ( 2020-2021) (Million US$)
Table Central & South America Key Players mRNA Vaccine And Therapeutics Market Share ( 2020-2021)
Table Central & South America mRNA Vaccine And Therapeutics Market Size by Type 2016-2021 (Million US$)
Table Central & South America mRNA Vaccine And Therapeutics Market Share by Type 2016-2021
Table Central & South America mRNA Vaccine And Therapeutics Market Size by Application 2016-2021 (Million US$)
Table Central & South America mRNA Vaccine And Therapeutics Market Share by Application 2016-2021
Table Argos Therapeutics Company Details
Table Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Argos Therapeutics Recent Development
Table BioNTech Company Details
Table BioNTech Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table BioNTech Recent Development
Table CureVac Company Details
Table CureVac Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table CureVac Recent Development
Table eTheRNA Company Details
Table eTheRNA Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table eTheRNA Recent Development
Table Ethris Company Details
Table Ethris Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Ethris Recent Development
Table In-Cell-Art Company Details
Table In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table In-Cell-Art Recent Development
Table Moderna Therapeutics Company Details
Table Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Moderna Therapeutics Recent Development
Table Sangamo Therapeutics Company Details
Table Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Sangamo Therapeutics Recent Development
Table Tiba Biotechnology Company Details
Table Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Tiba Biotechnology Recent Development
Table Translate Bio Company Details
Table Translate Bio Revenue in mRNA Vaccine And Therapeutics Business 2016-2021 (Million US$)
Figure Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business ( 2016-2021)
Table Translate Bio Recent Development
Table Global mRNA Vaccine And Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global mRNA Vaccine And Therapeutics Market Size Share by Regions ( 2021-2027)
Figure Global mRNA Vaccine And Therapeutics Market Size Share by Regions in 2027
Figure North America mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure Europe mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure China mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure Japan mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure Southeast Asia mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure India mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Figure Central & South America mRNA Vaccine And Therapeutics Market Size Forecast ( 2021-2027)(Million USD)
Table Global mRNA Vaccine And Therapeutics Market Size by Product ( 2021-2027) (Million US$)
Figure Global mRNA Vaccine And Therapeutics Market Size by Product ( 2021-2027)
Figure Global mRNA Vaccine And Therapeutics Market Size by Product in 2027
Table Global mRNA Vaccine And Therapeutics Market Size by Application ( 2021-2027) (Million US$)
Figure Global mRNA Vaccine And Therapeutics Market Size by Application ( 2021-2027)
Figure Global mRNA Vaccine And Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo
×

Avail PDF Sample Reports

You may also be lnterested in..

Research Allied Copyright © 2024 .